Are there any attempts to gain ground? Vera Therapeutics Inc (VERA) Stock

Oppenheimer raised the price target for the Vera Therapeutics Inc (NASDAQ:VERA) stock to “an Outperform”. The rating was released on January 25, 2024, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was upgraded by Jefferies, who disclosed in a […]

There Is Nothing Like Vera Therapeutics Inc (VERA) Stock

Oppenheimer raised the price target for the Vera Therapeutics Inc (NASDAQ:VERA) stock to “an Outperform”. The rating was released on January 25, 2024, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was upgraded by Jefferies, who disclosed in a […]

A healthy upside potential exists for Vera Therapeutics Inc (VERA) Stock

Oppenheimer raised the price target for the Vera Therapeutics Inc (NASDAQ:VERA) stock to “an Outperform”. The rating was released on January 25, 2024, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was upgraded by Jefferies, who disclosed in a […]

Is this a gain, a loss, or a throwaway? Vera Therapeutics Inc (VERA) Stock

Oppenheimer raised the price target for the Vera Therapeutics Inc (NASDAQ:VERA) stock to “an Outperform”. The rating was released on January 25, 2024, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was upgraded by Jefferies, who disclosed in a […]

Vera Therapeutics Inc (VERA) Stock is Just Right Size-Neither Too Big Nor Too Small

Oppenheimer raised the price target for the Vera Therapeutics Inc (NASDAQ:VERA) stock to “an Outperform”. The rating was released on January 25, 2024, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was upgraded by Jefferies, who disclosed in a […]

Getting Ready for the Bounce: Vera Therapeutics Inc (VERA) Stock

Oppenheimer raised the price target for the Vera Therapeutics Inc (NASDAQ:VERA) stock to “an Outperform”. The rating was released on January 25, 2024, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $29. The stock was upgraded by Jefferies, who disclosed in a […]